col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: Newlands Press Ltd
  original article Journal Date Title Authors All Authors
1 [GO] Therapeutic Delivery 2021―Oct―21 The latest developments in the area of therapeutic delivery excluding some diseases, such as COVID-19 and the big three (HIV/AID, malaria and tuberculosis) Catarina Pinto Reis
2 [GO] Bioanalysis 2021―Oct―14 Rapid development of analytical methods for evaluating pandemic vaccines: a COVID-19 perspective Jeremy Baldwin, Sakshi Piplani, Isaac G Sakala, Yoshikazu Honda-Okubo, Lei Li, Nikolai Petrovsky
3 [GO] Bioanalysis 2021―Sep―13 Deploying a rapid point of care polymerase chain reaction test for SARS-CoV-2 in a clinical research unit to ensure healthy volunteer safety Radboud van Trigt, Jason Neat, Jan Leendert Brouwer, Amanda Hays, Hans Westerhof
4 [GO] Future Medicinal Chemistry 2021―Sep―02 COVID-19 diagnostic assays sensitivity: lessons for the upcoming wave or next pandemic Nikhil Shri Sahahjpal, Ashis K Mondal, Sudha Ananth, Kimya Jones, Alka Chaubey, Ravindra Kolhe
5 [GO] Bioanalysis 2021―Aug―31 Volumetric absorptive microsampling: its use in COVID-19 research and testing James Rudge, Stuart Kushon
6 [GO] Bioanalysis 2021―Aug―31 A minireview on nanoparticle-based sensors for detection of coronaviruses Elaheh Rahimpour, Farzaneh Lotfipour, Abolghasem Jouyban
7 [GO] Bioanalysis 2021―Aug―18 Special Focus Issue - COVID-19: bioanalytical considerations, contributions and lessons - part 1 Sankeetha Nadarajah
8 [GO] Bioanalysis 2021―Aug―10 COVID-19’s impact on bioanalytical labs Amy Lavelle, Janine Micheli
9 [GO] Bioanalysis 2021―Aug―06 Efficiency of pooled surveillance testing in academic labs to detect and inhibit COVID-19 outbreaks John C Sitko, James Jordan Steel, Erin A Almand, Christopher A Cullenbine, Joseph W Rohrer, Douglas P Wickert, Steven CM Hasstedt
10 [GO] Bioanalysis 2021―Jul―22 Detection of SARS-CoV-2 at the point of care Michael J Loeffelholz, Yi-Wei Tang
11 [GO] Bioanalysis 2021―Jul―21 Rapid diagnostics for SARS-CoV-2 virus: point-of-care testing and lessons learned during the pandemic Trieu Nguyen, Anders Wolff
12 [GO] Bioanalysis 2021―Jul―19 How the COVID-19 pandemic is changing clinical trial conduct and driving innovation in bioanalysis Melanie Anderson
13 [GO] Bioanalysis 2021―Jul―19 Lessons learned from the COVID pandemic and its impact on bioanalysis and drug development Enaksha R Wickremsinhe, Catherine L Brockus, Anthony T Murphy
14 [GO] Future Medicinal Chemistry 2021―Jun―25 Rapid structure-based identification of potential SARS-CoV-2 main protease inhibitors M Elizabeth Sobhia, G Siva Kumar, Srikanth Sivangula, Ketan Ghosh, Harmanpreet Singh, Thongtinlal Haokip, Joseph Gibson
15 [GO] Future Medicinal Chemistry 2021―Jun―25 Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening Leonardo Bruno Federico, Guilherme Martins Silva, Lorane Izabel da Silva Hage-Melim, Suzane Quintana Gomes, Mariana Pegrucci Barcelos, Isaque Antônio Galindo Francischini, Carlos Henrique Tomich de Paula da Silva
16 [GO] Therapeutic Delivery 2021―Apr―07 Therapeutic potential of inhalable medications to combat coronavirus disease-2019 Vineela Parvathaneni, Nishant S Kulkarni, Aaron Muth, Nitesh K Kunda, Vivek Gupta
17 [GO] Therapeutic Delivery 2021―Feb―24 An overview of vaccine development for COVID-19 Seyed H Shahcheraghi, Jamshid Ayatollahi, Alaa AA Aljabali, Madhur D Shastri, Shakti D Shukla, Dinesh K Chellappan, et al. (+16)
18 [GO] Future Medicinal Chemistry 2021―Feb―16 De novo design of new chemical entities for SARS-CoV-2 using artificial intelligence Navneet Bung, Sowmya R Krishnan, Gopalakrishnan Bulusu, Arijit Roy
19 [GO] Bioanalysis 2021―Feb―04 Adaptation of Elecsys® anti-severe acute respiratory syndrome coronavirus-2 immunoassay to dried blood spots: proof of concept Alexandre Marchand, Ingrid Roulland, Florian Semence, Magnus Ericsson
20 [GO] Future Medicinal Chemistry 2021―Jan―20 The potential association between PARP14 and the SARS-CoV-2 infection (COVID-19) Amanda L Tauber, Stephanie S Schweiker, Stephan M Levonis
21 [GO] Pharmaceutical Patent Analyst 2021―Jan―15 Repurposing drugs during the COVID-19 pandemic and beyond Srividya Ravi, Sammita Jadhav, Anuradha Vaidya, Ravindra Ghooi
22 [GO] Bioanalysis 2021―Jan―11 Key points of technical review for the registration of SARS-CoV-2 antigen/antibody tests Hongran Li, Jingyun He, Wen Bao, Peirong Wang, Yunfeng Lv, Chao Xu, et al. (+6)
23 [GO] Future Medicinal Chemistry 2021―Jan―08 Can natural products stop the SARS-CoV-2 virus? A docking and molecular dynamics study of a natural product database Jurica Novak, Hrvoje Rimac, Shivananda Kandagalla, Maria A Grishina, Vladimir A Potemkin
24 [GO] Bioanalysis 2020―Dec―16 China NMPA perspective on clinical evaluation of SARS-CoV-2 antibody test reagents in the process of emergency approval Yunfeng Lv, Jingyun He, Rongzhi Liu, Yu Gao, Chao Xu, Peng Hu, et al. (+6)
25 [GO] Bioanalysis 2020―Dec―15 Validation of dried blood spot sample modifications to two commercially available COVID-19 IgG antibody immunoassays Theodore T Zava, David T Zava
26 [GO] Future Drug Discovery 2020―Dec―15 COVID-19 vaccines: challenges and promises of trials, manufacturing and allocation of doses Benedetta Spadaro
27 [GO] Future Drug Discovery 2020―Dec―03 High-throughput approaches of diagnosis and therapies for COVID-19: antibody panels, proteomics and metabolomics Rwik Sen
28 [GO] Future Medicinal Chemistry 2020―Nov―24 COVID-19 screening in a healthcare or community setting: complexity of saliva as a specimen for PCR-based testing Nikhil Shri Sahajpal, Ashis K Mondal, Allan Njau, Sudha Ananth, Salil Ghamande, Madhuri Hegde, et al. (+3)
29 [GO] Future Drug Discovery 2020―Oct―01 Withania somnifera as a potential future drug molecule for COVID-19 Vivek K Kashyap, Anupam Dhasmana, Murali M Yallapu, Subhash C Chauhan, Meena Jaggi
30 [GO] Bioanalysis 2020―Sep―11 How ADA methodology informs SARS-CoV-2 assay development Caroline Becker
31 [GO] Bioanalysis 2020―Aug―21 Safety considerations in the bioanalytical laboratories handling specimens from coronavirus disease 2019 patients Zhuo Chen, Timothy W Sikorski
32 [GO] Future Medicinal Chemistry 2020―Aug―13 Ligand and structure-based virtual screening applied to the SARS-CoV-2 main protease: an in silico repurposing study Witor Ribeiro Ferraz, Renan Augusto Gomes, Andre Luis S Novaes, Gustavo Henrique Goulart Trossini
33 [GO] Bioanalysis 2020―Jul―31 Could breath analysis by MS could be a solution to rapid, non-invasive testing for COVID-19? Heather J Walker, Michael M Burrell
34 [GO] Future Medicinal Chemistry 2020―Jul―16 Evidence supporting the use of peptides and peptidomimetics as potential SARS-CoV-2 (COVID-19) therapeutics Sonya VanPatten, Mingzhu He, Ahmad Altiti, Kai F Cheng, Mustafa H Ghanem, Yousef Al-Abed
35 [GO] Future Medicinal Chemistry 2020―Jul―08 Research progress on repositioning drugs and specific therapeutic drugs for SARS-CoV-2 Shiyong Fan, Dian Xiao, Yanming Wang, Lianqi Liu, Xinbo Zhou, Wu Zhong
36 [GO] Therapeutic Delivery 2020―Jun―29 The potential role of nanomedicine on COVID-19 therapeutics Rubiana Mara Mainardes, Camila Diedrich
37 [GO] Future Medicinal Chemistry 2020―Jun―26 Vesicular drug-delivery systems as theranostics in COVID-19 Saurabh Satija, Meenu Mehta, Mousmee Sharma, Parteek Prasher, Gaurav Gupta, Dinesh K Chellappan, Kamal Dua
38 [GO] Bioanalysis 2020―Jun―26 Bioanalytical research and training in academia during the COVID-19 pandemic Frank Klont, Gérard Hopfgartner
39 [GO] Bioanalysis 2020―Jun―23 Laboratory considerations amidst the coronavirus disease 2019 outbreak: the Spedali Civili in Brescia experience Emirena Garrafa, Duilio Brugnoni, Mosè Barbaro, Laura Andreoli, Emanuele Focà, Massimo Salvetti, et al. (+6)
40 [GO] Future Medicinal Chemistry 2020―Jun―22 Tackling SARS-CoV-2: proposed targets and repurposed drugs Siddhi Joshi, Maithili Joshi, Mariam S Degani
41 [GO] Future Medicinal Chemistry 2020―Jun―19 Role of clinical laboratories in response to the COVID-19 pandemic Nikhil Shri Sahajpal, Allan Njau, Ashis K Mondal, Sudha Ananth, Alka Chaubey, Amyn Rojiani, Ravindra Kolhe
42 [GO] Bioanalysis 2020―Jun―12 Virtual drug testing: redefining sample collection in a global pandemic Matthew N Fedoruk
43 [GO] Future Drug Discovery 2020―May―27 Overcoming nonstructural protein 15-nidoviral uridylate-specific endoribonuclease (nsp15/NendoU) activity of SARS-CoV-2 Suranga L Senanayake
44 [GO] Bioanalysis 2020―May―26 Rapid and robust bioanalytical assays are critical for SARS-CoV-2 therapeutic and vaccine development and beyond Sumit Kar, Rafiqul Islam
45 [GO] Therapeutic Delivery 2020―May―13 COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics Haneen Amawi, Ghina'a I Abu Deiab, Alaa A A Aljabali, Kamal Dua, Murtaza M Tambuwala
46 [GO] Bioanalysis 2020―Apr―15 Exhaled breath condensate as a potential specimen for diagnosing COVID-19 Maryam Khoubnasabjafari, Vahid Jouyban-Gharamaleki, Reza Ghanbari, Abolghasem Jouyban
47 [GO] Bioanalysis 2020―Apr―14 Managing bioanalytical studies during the COVID-19 pandemic: an overview Peter Pruim, Naomi Teekamp
48 [GO] Future Drug Discovery 2020―Mar―25 Drug repurposing strategies for COVID-19 Suranga L Senanayake


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.007 sec